Anxiety Disorder News and Research

RSS

S107 drug can prevent learning and memory deficits associated with stress-related disorders

Columbia University Medical Center (CUMC) researchers have identified a potential medical treatment for the cognitive effects of stress-related disorders, including post-traumatic stress disorder (PTSD).

31 Aug 2012

Nicotine dependence risk increased in bipolar disorder

Adults with mood and anxiety disorders are significantly more likely to be smokers than the general population, a US study of data from the National Epidemiologic Survey of Alcohol and Related Conditions shows.

23 Aug 2012

Social phobia prevalent in OCD patients

Social phobia is common among patients with obsessive compulsive disorder and frequently co-occurs with other related disorders, researchers report.

21 Aug 2012

Two papers may help identify gene variants that contribute to OCD or Tourette syndrome

Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.

15 Aug 2012

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.

23 Jul 2012

Anxiety in poor mothers not a psychiatric problem but a reaction to severe environmental deficits

Poor mothers are more likely to be classified as having the mental illness known as generalized anxiety disorder (GAD) because they live in poverty - not because they are suffering from a psychiatric disorder, according to Rutgers researchers.

21 Jul 2012

Factors linked with MDD transition to BD identified

A wide range of demographic, clinical, and environmental factors are associated with an increased risk for transition from major depressive disorder to bipolar disorder, US study results show.

10 Jul 2012

Factors linked with MDD transition to BD identified

A wide range of demographic, clinical, and environmental factors are associated with an increased risk for transition from major depressive disorder to bipolar disorder, US study results show.

10 Jul 2012

Researchers investigate whether PTSD is a brain disorder

Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating whether post traumatic stress disorder (PTSD) is a brain disorder that can affect multiple parts of the body and cause lifelong illnesses.

10 Jul 2012

One in eight people with heart attack experience significant symptoms of PTSD

One in eight people who suffer a heart attack or other acute coronary event experience clinically significant symptoms of post-traumatic stress disorder (PTSD), according to a meta-analysis of 24 studies led by Columbia University Medical Center researchers.

21 Jun 2012

Link between unconscious conflicts and conscious anxiety disorder symptoms

An experiment that Sigmund Freud could never have imagined 100 years ago may help lend scientific support for one of his key theories, and help connect it with current neuroscience.

18 Jun 2012

ABM treatments can address childhood anxiety

According to the Anxiety and Depression Association of America, one in eight children suffers from an anxiety disorder. And because many anxious children turn into severely anxious adults, early intervention can have a major impact on a patient's life trajectory. The understandable reluctance to use psychiatric medications when it comes to children means child psychologists are always searching for viable therapeutic alternatives.

12 Jun 2012

Brains of anxious girls work much harder than those of boys

In a discovery that could help in the identification and treatment of anxiety disorders, Michigan State University scientists say the brains of anxious girls work much harder than those of boys.

6 Jun 2012

Interim data from UCLA and NeuroSigma’s eTNS Phase I trial on PTSD, MDD

Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.

31 May 2012

Reducing off-label antipsychotic use may generate savings with little impact on patient care

Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.

16 May 2012

Simple two-question test more effective in identifying anxiety disorders in children

A University of British Columbia researcher has developed a simple two-question test to screen kindergarten-aged children for future anxiety disorders - the most commonly reported mental health concern among children.

17 Apr 2012

Intelligence may have co-evolved with worry in humans

Worrying may have evolved along with intelligence as a beneficial trait, according to a recent study by scientists at SUNY Downstate Medical Center and other institutions.

16 Apr 2012

Research roundup: Effects of health exchanges; Improving provider performance; Governors' 2013 budgets and Medicaid

Authors analyzed the cost and coverage implications of various scenarios of the health insurance exchanges that are called for in the health law. They predicted that about 1 million uninsured people in the state would get insurance through the exchanges and said that premiums in the small group and individual market would be lower than if the health law was not in effect.

7 Apr 2012

Teva, IVAX receive FDA approval for generic Lexapro to treat depression and GAD

The U.S. Food and Drug Administration today approved the first generic Lexapro (escitalopram tablets) to treat both depression and generalized anxiety disorder in adults.

27 Mar 2012

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro

Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.

15 Mar 2012

Anxiety Disorder News and Research

S107 drug can prevent learning and memory deficits associated with stress-related disorders

Nicotine dependence risk increased in bipolar disorder

Social phobia prevalent in OCD patients

Two papers may help identify gene variants that contribute to OCD or Tourette syndrome

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Anxiety in poor mothers not a psychiatric problem but a reaction to severe environmental deficits

Factors linked with MDD transition to BD identified

Factors linked with MDD transition to BD identified

Researchers investigate whether PTSD is a brain disorder

One in eight people with heart attack experience significant symptoms of PTSD

Link between unconscious conflicts and conscious anxiety disorder symptoms

ABM treatments can address childhood anxiety

Brains of anxious girls work much harder than those of boys

Interim data from UCLA and NeuroSigma’s eTNS Phase I trial on PTSD, MDD

Reducing off-label antipsychotic use may generate savings with little impact on patient care

Simple two-question test more effective in identifying anxiety disorders in children

Intelligence may have co-evolved with worry in humans

Research roundup: Effects of health exchanges; Improving provider performance; Governors' 2013 budgets and Medicaid

Teva, IVAX receive FDA approval for generic Lexapro to treat depression and GAD

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News